No­var­tis of­fers $25M more in med­ical aid to Ukraine while sus­pend­ing sev­er­al ac­tiv­i­ties in Rus­sia

As the war in Ukraine con­tin­ues to in­ten­si­fy, phar­ma gi­ant No­var­tis has de­tailed its cam­paign to of­fer hu­man­i­tar­i­an re­lief while stick­ing to a hard line …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.